American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (988)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (941)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1257)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (4000)
  2. Hematologic Malignancies, Division of (3803)
  3. Center for Hematologic Malignancies (3680)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1343)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (312)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (64)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5174)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Machine learning for prediction of cancer-associated venous thromboembolism
    Meeting Abstract

    Mantha, S.; Dunbar, A.; Bolton, K. L.; Devlin, S.; Gorenshteyn, D.; Donoghue, M.; Arcila, M. E.; Soff, G. A.
    Blood (2020)

    Fulltext@MSK | Save
  • Prediction of COVID-19 mortality in patients with cancer
    Meeting Abstract

    Mantha, S.; Jee, J.; Soff, G. A.; Pessin, M. S.
    Blood (2020)

    Fulltext@MSK | Save
  • Loss of LKB1/(STK11) facilitates leukemic progression of the myeloproliferative neoplasms
    Meeting Abstract

    Marinaccio, C.; Suraneni, P. K.; Celik, H.; Volk, A.; Wen, J. Q.; Ling, T.; Lasho, T.; Koche, R. P.; Famulare, C.; Stein, B. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • TET2 and DNMT3A mutations exert divergent effects on DNA repair and sensitivity of leukemia cells to PARP inhibitors
    Meeting Abstract

    Maifrede, S.; Le, B. V.; Nieborowska-Skorska, M.; Golovine, K.; Sullivan-Reed, K.; Dunuwille, W. M. B.; Nacson, J.; Hulse, M.; Caruso, L. B.; Gazze, Z.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • CARTITUDE-1: Phase 1b/2 study of ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T cell therapy, in relapsed/refractory multiple myeloma
    Meeting Abstract

    Madduri, D.; Berdeja, J. G.; Usmani, S. Z.; Jakubowiak, A.; Agha, M.; Cohen, A. D.; Stewart, A. K.; Hari, P.; Htut, M.; O'Donnell, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Clonal hematopoiesis and its implications for flow cytometric assessment of measurable residual disease in patients with NPM1-mutated acute myeloid leukemia
    Meeting Abstract

    Loghavi, S.; DiNardo, C. D.; Takahashi, K.; Kanagal-Shamanna, R.; Tanaka, T.; Furudate, K.; Short, N. J.; Kadia, T. M.; Konopleva, M.; Farnoud, N.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Copy number signatures predict chromothripsis and poor clinical outcome in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Derkach, A.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • The genomic complexity of multiple myeloma precursor disease can be predicted using copy number signatures on targeted sequencing and SNP array data
    Meeting Abstract

    Maclachlan, K. H.; Zheng-Lin, B.; Yellapantula, V.; Rustad, E. H.; Diamond, B.; Hultcrantz, M.; Dogan, A.; Zhang, Y.; Morgan, G.; Landgren, O.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Evaluation of minimal residual disease (MRD) negativity in patients with relapsed or refractory multiple myeloma treated in the CANDOR Study
    Meeting Abstract

    Landgren, O.; Weisel, K.; Dachs, L. R.; Moreau, P.; Turgut, M.; Hajek, R.; Mollee, P.; Kim, J. S.; Zhang, J.; Go, N.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • HORIZON (OP-106): Melflufen plus dexamethasone in patients with relapsed/refractory multiple myeloma-age subgroup analysis of elderly patients
    Meeting Abstract

    Larocca, A.; Richardson, P. G.; Oriol, A.; Creixenti, J. B.; Cavo, M.; Rodríguez-Otero, P.; Leleu, X.; Norkin, M.; Nadeem, O.; Hiemenz, J. W.; more...
    Blood (2020)

    Fulltext@MSK | Save